Osteoprotegerin in the Inner Ear May Inhibit Bone Remodeling in the Otic Capsule
β Scribed by Andreas F. Zehnder; Arthur G. Kristiansen; Joe C. Adams; Saumil N. Merchant; Michael J. McKenna
- Book ID
- 110087551
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 822 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Dasatinib is a potent tyrosine kinase inhibitor that is used to treat chronic myeloid leukemia in patients resistant or intolerant to imatinib mesylate. While designed to inhibit Abl and Src kinases, dasatinib shows multitarget effects, including inhibition of the macrophage colonyβstim
There is increasing evidence that extracellular nucleotides act on bone cells via multiple P2 receptors. The naturally-occurring ligand ATP is a potent agonist at all receptor subtypes, whereas ADP and UTP only act at specific receptor subtypes. We have reported that the formation and resorptive act